论文部分内容阅读
目的探讨在上消化道出血患者中联用奥美拉唑与血凝酶治疗的作用。方法随机将近两年时间到我院治疗的64例上消化道出血患者分组,对照组32例单纯予奥美拉唑用药,观察组32例选择奥美拉唑联合血凝酶方案治疗,连用3d后,针对两组的总体治疗情况作比较和评估。结果经相应方案治疗,观察组的总治愈率达96.88%,与对照组的78.13%相比有明显增高,有统计学意义(P<0.05)。在平均止血时间上,观察组为(2.52±0.47)d,相比对照组的(4.01±1.26)d明显缩短,有统计学意义(P<0.05)。结论采取奥美拉唑与血凝酶方案对上消化道出血患者进行联合用药,总体止血效果更理想,且安全可靠,适合在临床推广。
Objective To investigate the effect of combination of omeprazole and hemagglutinin in patients with upper gastrointestinal hemorrhage. Methods A total of 64 cases of upper gastrointestinal bleeding were randomized in our hospital for nearly two years. 32 cases in the control group were treated with omeprazole alone. In the observation group, 32 cases were treated with omeprazole and hemagglutinating enzyme. After the two groups for the overall treatment for comparison and evaluation. Results After the corresponding treatment, the total cure rate in the observation group was 96.88%, which was significantly higher than 78.13% in the control group (P <0.05). In the mean hemostasis time, the observation group was (2.52 ± 0.47) d, which was significantly shorter than that of the control group (4.01 ± 1.26) d, with statistical significance (P <0.05). Conclusion The omeprazole and hemagglutinin regimen combined with upper gastrointestinal bleeding patients, the overall hemostatic effect is more ideal, safe and reliable, suitable for clinical promotion.